Alpha7 Neuronal Nicotinic Receptors as Targets for Novel Therapies to Treat Multiple Domains of Schizophrenia

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-03 ,pp. : 437-448

Bentham Science Publishers

Access to resources Recommend Favorite

Nicotinic Receptors and the Treatment of Attentional and Cognitive Deficits in Neuropsychiatric Disorders: Focus on the 7 Nicotinic Acetylcholine Receptor as a Promising Drug Target for Schizophrenia

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 7, Iss. 4, 2007-12 ,pp. : 269-288

Bentham Science Publishers

Access to resources Recommend Favorite

Alpha7 Neuronal Nicotinic Receptor: A Pluripotent Target for Diseases of the Central Nervous System

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 5, 2014-06 ,pp. : 836-845

Bentham Science Publishers

Access to resources Recommend Favorite

Are neuronal nicotinic receptors a target for antiepileptic drug development? Studies in different seizure models in mice and rats

By Loscher W.   Potschka H.   Wlaz P.   Danysz W.   Parsons C.G.  

European Journal of Pharmacology, Vol. 466, Iss. 1, 2003-04 ,pp. : 99-111

Elsevier

Access to resources Recommend Favorite

Neuronal nicotinic acetylcholine receptors as drug targets

By Suto Mark J   Zacharias Niki  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 2, 2004-04 ,pp. : 61-64

Informa Healthcare

Access to resources Recommend Favorite